Name: 글로벌 시장 동향
SKU: DMMD1281
Availability: InStock

보고서 요약(국문)

시장 개요
전 세계 심장 부정맥 모니터링 장치 시장 규모는 2023년 XX백만 달러였으며, 2030년까지 XX백만 달러에 이를 것으로 예상되며, 예측 기간(2023-2030) 동안 연평균 성장률(CAGR)은 YY%입니다.
심장 부정맥 모니터링은 불규칙한 심장 박동 또는 심장 리듬의 원인과 유형을 파악하는 데 사용되는 검사입니다. 심장 박동을 모니터링하거나 관찰하는 데 사용되는 장치를 심장 부정맥 모니터링 장치라고 합니다. 심장 리듬 모니터링을 위해 개발된 제품으로는 홀터 모니터, 모바일 심장 원격 측정 장치 또는 ECG 장치 등이 있습니다.
시장 동향
전 세계 심장 부정맥 모니터링 장치 시장 성장을 견인하는 주요 요인은 심혈관 질환 발병률 증가로 인한 스마트 심장 모니터링 장치에 대한 수요 증가, 더 나은 치료를 위한 지속적인 모니터링의 필요성, 인식 개선 활동의 증가, 기술 발전으로 인한 신제품 출시 등입니다.

스마트 심장 모니터의 개발 증가와 원격 심장 진료에 대한 수요 증가가 시장 성장을 견인할 것으로 예상됩니다.
심장 부정맥 모니터링 장치 시장은 원격 심장 진료 수요 증가, 기술 발전, 고령 인구 증가, 연구 개발 투자 증가, 만성 심혈관 질환 환자 수 증가, 최신 기술을 활용한 신제품 개발, 그리고 신흥 시장의 의료 인프라 개선에 힘입어 성장하고 있습니다.
심장 부정맥 모니터링 장치는 심장 박동을 지속적으로 모니터링하여 질환을 적절하게 관리하는 데 널리 사용됩니다. 이러한 장치의 도입이 증가함에 따라 정부의 지원과 자금 투입도 늘어나고 있습니다. 이러한 자금은 스마트 심장 모니터나 스마트워치와 같은 더욱 발전된 모니터링 제품 개발에 도움이 될 것입니다. 심혈관 질환 환자 수 증가로 인해 전 세계적으로 심장 부정맥 모니터링 장치 시장이 성장하고 있습니다. 또한, 주요 업체들의 기술적으로 진보된 제품 출시 또한 시장 성장에 중요한 역할을 할 것으로 예상됩니다.

다양한 신제품 출시, 연구 조사, 그리고 심장 부정맥 모니터링 장치와 관련된 인식 제고 활동이 시장 성장에 기여하고 있습니다. 예를 들어, 심장 질환 관리에 중점을 둔 디지털 헬스케어 솔루션 기업인 iRhythm Technologies, Inc.는 2021년 5월 24일 두 가지 신제품에 대한 510(k) 승인을 발표했습니다. 하나는 디자인이 개선된 새로운 플래그십 모니터에 대한 승인이고, 다른 하나는 향상된 인공지능(AI) 기능에 대한 승인입니다. 새로운 Zio 모니터는 환자의 편안함을 향상시키도록 개발되었으며, AI 기능 향상을 통해 심장 박동 및 리듬 진단 정확도를 더욱 높일 것입니다.
불확실한 보험금 지급 정책은 시장 성장을 저해할 것으로 예상됩니다.
특히, 이러한 심장 모니터링 장치와 관련된 불확실한 보험금 지급 정책은 시장 성장을 저해하는 주요 요인입니다. 이러한 불확실성으로 인해 의료진과 환자 모두 모니터링 장치 도입을 주저하게 됩니다.
심혈관 질환 또는 상태 모니터링에 사용되는 이러한 장치의 승인에 대한 엄격한 규정 또한 심장 부정맥 모니터링 장치 시장 성장을 저해하는 요인입니다. 스마트 심장 모니터나 스마트워치와 같은 고도화된 모니터의 높은 가격 또한 시장 성장을 제한하는 요인이 될 수 있습니다.
COVID-19 영향 분석
코로나19 팬데믹은 전 세계 재정 전망, 운영 및 위기 대응 전략에 부정적인 영향을 미쳤습니다. 특히 COVID-19 발생은 의료 산업에 심각한 타격을 입혔습니다. 심장 부정맥 모니터링 기기 시장은 COVID-19로 인해 막대한 손실을 경험했습니다. 주요 제조업체들은 다양한 연구 및 임상 시험을 시작했으며, 전 세계적으로 다양한 계획, 제품 출시, 협력 및 합병이 진행되면서 시장 성장을 촉진하고 있습니다. 예를 들어, 심장 질환 관리 발전에 중점을 둔 디지털 헬스케어 솔루션 기업인 iRhythm Technologies, Inc.는 2022년 7월 22일 미국 식품의약국(FDA)으로부터 Zio Watch의 ZEUS 시스템(Zio ECG 활용 소프트웨어)에 대한 승인을 받았다고 발표했습니다. 이 시스템은 정밀 의료 기업인 Verily와 협력하여 개발되었으며, 신뢰할 수 있는 심장 부정맥 서비스와 딥러닝 알고리즘을 결합한 것입니다.

세그먼트 분석
홀터 모니터 부문은 예측 기간(2023-2030년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
홀터 모니터 부문은 전 세계 심장 부정맥 모니터링 장치 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 전 세계 심장 부정맥 모니터링 장치 시장은 제품 유형별로 홀터 모니터, 심전도(ECG) 장치, 모바일 심장 원격 측정 장치, 심장 이벤트 모니터, 이식형 루프 레코더, 패치 모니터, 심박 조율기, 심장 제세동기 등으로 세분화됩니다. 홀터 모니터 부문이 가장 큰 시장 점유율을 차지하는 이유는 전 세계적으로 모니터링을 위한 이러한 장치의 채택이 증가하고, 기술 발전이 가속화되고, 신제품 출시가 활발히 이루어지고 있기 때문입니다.
홀터 모니터는 심장 박동을 기록하는 작고 착용 가능한 장치입니다. 이는 불규칙한 심장 박동(부정맥) 위험을 판단하거나 감지하는 데 사용됩니다. 홀터 모니터 검사는 일반적으로 기존 심전도 검사에서 심장 상태에 대한 충분한 정보를 얻을 수 없을 때 시행됩니다. 이 모니터는 심전도 검사에서 놓칠 수 있는 불규칙한 심장 박동을 감지할 수 있습니다. 홀터 모니터링은 비침습적이고 통증이 없습니다. 모니터는 보통 1~2일 동안 착용하며, 이 기간 동안 모든 심장 박동이 기기에 기록됩니다. 센서와 전선은 옷 아래에 쉽게 숨길 수 있습니다. 기기는 스트랩이나 벨트에 부착하여 착용할 수 있습니다.
규제 승인 증가, 기술 발전, 신제품 출시, 연구/임상 시험 진행 등이 시장 성장을 견인하고 있습니다. 예를 들어, 헬스케어 기술 기업인 로열 필립스는 2022년 1월 26일, 분산형 임상 시험에 활용 가능한 최초의 가정용 종합 12유도 심전도(ECG) 솔루션을 출시한다고 발표했습니다. 이 임상 등급 솔루션은 필립스의 심장 모니터링 포트폴리오에 포함된 고도로 발전된 환자 중심 ECG로, 필립스의 선도적인 클라우드 기반 데이터 수집 및 평가 서비스를 제공하는 현장 기반 ECG입니다.
지역 분석
북미는 전 세계 심장 부정맥 모니터링 기기 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.

북미는 인구 규모, 우수한 의료 인프라, 높은 소득 수준을 바탕으로 전 세계 심장 부정맥 모니터링 장치 시장을 주도하고 있습니다. 특히 미국의 의료비 지출 증가로 인해 예측 기간 동안 시장 규모는 비교적 완만하게 성장할 것으로 예상됩니다. 북미 시장의 상당한 규모는 높은 의료비 지출에 기인합니다.
의료비 지출 증가와 심장 부정맥에 대한 인식 제고 또한 이 지역 시장 성장에 기여하고 있습니다. 심박 조율기, 이벤트 모니터, ECG 장치, 홀터 모니터 등 심장 부정맥 모니터링 장치의 발전, 이 지역의 제약 회사 증가, 정부 승인 확대, 주요 업체들의 존재 또한 심장 부정맥 모니터링 장치 시장 성장에 영향을 미치고 있습니다.
또한, 신제품 출시 증가도 시장 성장에 중요한 역할을 하고 있습니다. 이 지역에서는 다양한 주요 개발, 기술 발전, 협력 및 계약이 활발하게 이루어지고 있습니다. 예를 들어, 의료용 스마트워치 개발에 참여하는 디지털 헬스 기업인 CardiacSense는 2021년 2월 10일 유럽 연합(EU)에서 자사의 의료용 스마트워치 제품의 판매 및 마케팅에 대한 CE 마크를 획득했다고 발표했습니다. 인증된 적응증에는 심박 변이도(HRV) 모니터링과 심전도(ECG) 및 연속 광혈량측정법(PPG)을 이용한 심방세동(A-Fib) 감지가 포함됩니다.

경쟁 환경
심장 부정맥 모니터링 기기 시장은 국내외 기업들이 경쟁하는 비교적 경쟁적인 시장입니다. 주요 기업으로는 Philips Healthcare, GE Healthcare, Medtronic PLC, Cardiac Sense, BIOTRONIK, iRhythm Technologies, Inc., Preventice Solutions (Boston Scientific Corporation), Medi-Lynx Cardiac Monitoring, LLC., ACS Diagnostics, Abbott 등이 있습니다. 이들 기업은 신제품 출시, 인수합병, 파트너십, 협력 등 다양한 성장 전략을 통해 시장 성장에 기여하고 있습니다. 예를 들어, 2021년 1월 21일, 보스턴 사이언티픽(Boston Scientific)은 모바일 심장 건강 솔루션 및 서비스 포트폴리오 전반을 제공하는 프리벤티스 솔루션즈(Preventice Solutions, Inc.)를 인수하는 최종 계약을 체결했다고 발표했습니다. 프리벤티스 솔루션즈는 장단기 홀터 모니터, 모바일 심장 원격 측정, 심장 이벤트 모니터 등의 휴대용 심장 모니터를 제공합니다.
GE 헬스케어
개요: GE 헬스케어는 미국 다국적 기업인 제너럴 일렉트릭(General Electric Company)의 자회사입니다. 이 회사는 의료 영상 시술에 사용되는 영상 진단용 조영제 및 방사성 의약품을 제조 및 유통합니다.
제품 포트폴리오:
CARESCAPE B850 모니터: GE 헬스케어의 EK-Pro 알고리즘을 통해 스마트 리드 오류 감지 및 4리드 부정맥 분석과 같은 첨단 기능을 탑재하고 있습니다. 또한, 국소 산소포화도(rSO2), 맥파 변동 지수(PVI), 관류 지수(PI), 총 헤모글로빈(SpHb) 등 다양한 기본 및 고급 임상 매개변수를 제공합니다.

주요 개발 사항: 2022년 7월 16일, GE Healthcare는 의료진이 환자의 상태 악화를 조기에 감지할 수 있도록 지원하는 세로형 모바일 무선 웨어러블 센서 기반 환자 모니터링 솔루션을 출시한다고 발표했습니다.
글로벌 심장 부정맥 모니터링 장치 시장 보고서는 약 45개 이상의 시장 데이터 표, 40개 이상의 그림, 그리고 약 200페이지 분량의 자료를 제공합니다.

보고서 요약(영어 원문)

Market Overview
The global cardiac arrhythmia monitoring devices market size was valued at US$ XX million in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of YY% during the forecast period (2023-2030).
Cardiac arrhythmia monitoring is a kind of test utilized to determine the cause and type of the irregular heart rates or heart rhythms. The devices utilized to monitor or observe the heart rates are the cardiac arrhythmia monitoring devices. There are numerous products developed for monitoring the heart rhythms including holter monitor, mobile cardiac telemetry or ECG devices.
Market Dynamics
The major factors driving the global cardiac arrhythmia monitoring devices market are the rising demand for smart cardiac monitoring devices owing to increasing incidences of cardiovascular disorders requiring continuous monitoring for better treatment, surging awareness initiatives, advancements in technologies leading to novel product launches.
The increasing development of smart cardiac monitors and rising demand for telecardiology are expected to drive the market’s growth.
The cardiac arrhythmia monitoring devices market is driven by increasing demand of telecardiology, rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of chronic cardiovascular diseases and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.
The cardiac arrhythmia monitoring devices are used widely for continuous monitoring of rhythms of heart for management of the condition properly. The adoption of these devices is increasing, leading to rising government initiatives and funds. These funds will help produce more developed products such as smart cardiac monitors or smart watches for monitoring. The market for these cardiac arrhythmia monitoring devices is increasing worldwide due to the enhanced number of people suffering from cardiovascular disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market’s growth.
Various novel product launches, research studies, and rising awareness initiatives related to these cardiac arrhythmia monitoring devices contribute to the market’s growth. For instance, in May 24, 2021, iRhythm Technologies, Inc., a company of digital healthcare solutions focused on cardiac care advancement announced two novel 510(k) clearances. One for a novel flagship monitors with better design and second for an improved artificial intelligence (AI) capabilities. The novel Zio monitor is developed to enhance patient comfort while its AI capabilities advancements will further improve beat and rhythm diagnostic accuracy.
Uncertain reimbursement policies are expected to hamper the market’s growth.
However uncertain reimbursement policies associated with these cardiac monitoring devices is the key factor which may hamper the market growth. Due to the uncertainty clinicians as well as patients hesitate in adopting these monitoring devices.
The strict rules and regulations for the approval of these devices utilized for monitoring of cardiovascular disorders or conditions is also a factor hindering the growth of the cardiac arrhythmia monitoring devices market. High costs of highly advanced monitors such as smart cardiac monitors or smart watches can also limit the growth of the market.
COVID-19 Impact Analysis
The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The cardiac arrhythmia monitoring devices market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market’s growth. For instance, July 22, 2022, iRhythm Technologies, Inc., a company of digital healthcare solutions focused on cardiac care advancement announced about receiving clearance for Zio Watch’s ZEUS System (Zio ECG Utilization Software) by USFDA. This system is developed in partnership with Verily, a precision health company. ZEUS System combines trusted cardiac arrhythmia service with deep learned algorithms.
Segment Analysis
The holter monitors segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)
The holter monitor segment is the highest market holder in the global cardiac arrhythmia monitoring devices market. The global cardiac arrhythmia monitoring devices market is segmented based on product as holter monitors, ECG devices, mobile cardiac telemetry, cardiac event monitors, implantable loop recorders, patch monitor, pacemaker, cardioverter-defibrillator. The holter monitors segment is the largest market shareholder due to the increasing adoption of these devices globally for monitoring, increasing technological advancements and novel product launches.
Holter monitors are the small and wearable device that records the rhythm of heart. It is utilized to determine or detect irregular heartbeats (arrhythmias) risk. Holter monitors test is usually done if a traditional electrocardiogram is unable to provide sufficient details about the condition of the heart. These monitors can spot irregular heart rhythms that may be missed by ECG. Holter monitoring is non-invasive and painless. The monitor is usually worn for 1 to 2 days in which all the heartbeats are recorded by the device. The sensors and the wires are easy to hide under clothing. The device can be attached to a strap or worn on a belt.
The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drives the market’s growth. For instance, in January 26, 2022, Royal Philips, a health technology company announced about introducing the first at-home, full-service, 12-lead electrocardiogram (ECG) solution that can be utilized in decentralized clinical trials. This clinical-grade solution is the highly advanced patient-centric ECG included within the cardiac monitoring portfolio of Philips, site-based ECGs with leading cloud-based data collection and evaluation services of Philips.
Geographical Analysis
North America holds the largest market share in the global cardiac arrhythmia monitoring devices market.
North America dominates the global cardiac arrhythmia monitoring devices market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market’s significant size is attributed to the high medical expenditure.
Increasing expenditure on healthcare and raising awareness among people is also contributing to the market’s growth in this region. Advancement of cardiac arrhythmia monitoring devices such as pacemaker, event monitors, ECG devices or holter monitors, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the cardiac arrhythmia monitoring devices market.
Moreover, the growing number of product launches is responsible for the market’s growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in February 10, 2021, CardiacSense, a digital health company involved in developing a medical grade watch announced about receiving the CE Mark for its medical grade smart watch device’s marketing & sales in the European Union. The certified indications include Heart Rate Variability (HRV) monitoring and detection of Atrial Fibrillation (A-Fib) with spot Electrocardiogram (ECG) and continuous Photoplethysmography (PPG).
Competitive Landscape
The cardiac arrhythmia monitoring devices market is moderately competitive with local and global companies’ presence. Philips Healthcare, GE Healthcare, Medtronic PLC, Cardiac Sense, BIOTRONIK, iRhythm Technologies, Inc., Preventice Solutions (Boston Scientific Corporation), Medi-Lynx Cardiac Monitoring, LLC., ACS Diagnostics, Abbott and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market’s growth. For instance, in January 21, 2021, Boston Scientific announced about entering into a definitive acquisition agreement with Preventice Solutions, Inc., a company offering a whole portfolio of mobile cardiac health solutions and services, including ambulatory cardiac monitors such as long and short-term Holter monitor, mobile cardiac telemetry and cardiac event monitors.
GE Healthcare
Overview: GE Healthcare is a subsidiary of American multinational conglomerate General Electric Company. The company manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures.
Product Portfolio:
CARESCAPE B850 monitor: It incorporates technologically advanced features including smart lead fail and four lead arrhythmia analysis facilitated by EK-Pro algorithm of GE Healthcare. The monitor also provide a broad range of basic or advanced clinical parameters such as regional oximetry (rSO2), plethysmography variability index (PVI), Perfusion Index (PI) and total hemoglobin (SpHb).
Key Development: In July 16, 2022, GE Healthcare announced about introducing portrait mobile continuous wireless wearable sensors patient monitoring solution for supporting clinicians in detecting early patient deterioration.
The global cardiac arrhythmia monitoring devices market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing development of smart cardiac monitors
4.1.1.2. Rising demand for telecardiology
4.1.2. Restraints:
4.1.2.1. Uncertain reimbursement policies
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1 Porter's Five Forces Analysis
5.2 Supply Chain Analysis
5.3 Pricing Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Holter Monitor *
7.2.1. Introduction
7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
7.3. ECG Devices
7.4. Mobile Cardiac Telemetry
7.5. Cardiac Event Monitors
7.6. Implantable Loop Recorders
7.7. Patch Monitor
7.8. Pacemaker
7.9. Cardioverter-Defibrillator
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Atrial Fibrillation *
8.2.1. Introduction
8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
8.3. Bradycardia
8.4. Atrial Tachycardia
8.5. Ventricular Tachycardia
8.6. Ventricular Fibrillation
8.7. Premature Contraction
8.8. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals *
9.2.1. Introduction
9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
9.3. Ambulatory Surgical Centers
9.4. Diagnostic Centers
9.5. Specialty Clinics
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Products Benchmarking
11.4. List of Key Companies to Watch
12. Company Profiles
12.1. Philips Healthcare *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. GE Healthcare
12.3. Medtronic PLC
12.4. Cardiac Sense
12.5. BIOTRONIK
12.6. iRhythm Technologies, Inc.
12.7. Preventice Solutions (Boston Scientific Corporation)
12.8. Medi-Lynx Cardiac Monitoring LLC.
12.9. ACS Diagnostics
12.10. Abbott
LIST NOT EXHAUSTIVE
13. Global Cardiac Arrhythmia Monitoring Devices Market – DataM
13.1. Appendix
13.2. About Us and Medications
13.3. Contact Us

언급된 주요 기업들

Philips Healthcare, GE Healthcare, Medtronic PLC, Cardiac Sense, BIOTRONIK, iRhythm Technologies, Inc., Preventice Solutions (Boston Scientific Corporation), Medi-Lynx Cardiac Monitoring LLC., ACS Diagnostics, Abbott

표 목록 (Tables)

List of Tables

Table 1 Global Cardiac Arrhythmia Monitoring Devices Market Value, By Product, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Cardiac Arrhythmia Monitoring Devices Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Cardiac Arrhythmia Monitoring Devices Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Cardiac Arrhythmia Monitoring Devices Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Cardiac Arrhythmia Monitoring Devices Market Value, By Product, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Cardiac Arrhythmia Monitoring Devices Market Value, By Product, 2022-2031 (US$ Million)

Table 7 Global Cardiac Arrhythmia Monitoring Devices Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Cardiac Arrhythmia Monitoring Devices Market Value, By Application, 2022-2031 (US$ Million)

Table 9 Global Cardiac Arrhythmia Monitoring Devices Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Cardiac Arrhythmia Monitoring Devices Market Value, By End User, 2022-2031 (US$ Million)

Table 11 Global Cardiac Arrhythmia Monitoring Devices Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Cardiac Arrhythmia Monitoring Devices Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Cardiac Arrhythmia Monitoring Devices Market Value, By Product, 2022-2031 (US$ Million)

Table 14 North America Cardiac Arrhythmia Monitoring Devices Market Value, By Application, 2022-2031 (US$ Million)

Table 15 North America Cardiac Arrhythmia Monitoring Devices Market Value, By End User, 2022-2031 (US$ Million)

Table 16 North America Cardiac Arrhythmia Monitoring Devices Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Cardiac Arrhythmia Monitoring Devices Market Value, By Product, 2022-2031 (US$ Million)

Table 18 South America Cardiac Arrhythmia Monitoring Devices Market Value, By Application, 2022-2031 (US$ Million)

Table 19 South America Cardiac Arrhythmia Monitoring Devices Market Value, By End User, 2022-2031 (US$ Million)

Table 20 South America Cardiac Arrhythmia Monitoring Devices Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Cardiac Arrhythmia Monitoring Devices Market Value, By Product, 2022-2031 (US$ Million)

Table 22 Europe Cardiac Arrhythmia Monitoring Devices Market Value, By Application, 2022-2031 (US$ Million)

Table 23 Europe Cardiac Arrhythmia Monitoring Devices Market Value, By End User, 2022-2031 (US$ Million)

Table 24 Europe Cardiac Arrhythmia Monitoring Devices Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market Value, By Product, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market Value, By Application, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market Value, By End User, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East & Africa Cardiac Arrhythmia Monitoring Devices Market Value, By Product, 2022-2031 (US$ Million)

Table 30 Middle East & Africa Cardiac Arrhythmia Monitoring Devices Market Value, By Application, 2022-2031 (US$ Million)

Table 31 Middle East & Africa Cardiac Arrhythmia Monitoring Devices Market Value, By End User, 2022-2031 (US$ Million)

Table 32 Philips Healthcare: Overview

Table 33 Philips Healthcare: Product Portfolio

Table 34 Philips Healthcare: Key Developments

Table 35 GE Healthcare: Overview

Table 36 GE Healthcare: Product Portfolio

Table 37 GE Healthcare: Key Developments

Table 38 Medtronic PLC: Overview

Table 39 Medtronic PLC: Product Portfolio

Table 40 Medtronic PLC: Key Developments

Table 41 Cardiac Sense: Overview

Table 42 Cardiac Sense: Product Portfolio

Table 43 Cardiac Sense: Key Developments

Table 44 BIOTRONIK: Overview

Table 45 BIOTRONIK: Product Portfolio

Table 46 BIOTRONIK: Key Developments

Table 47 iRhythm Technologies, Inc.: Overview

Table 48 iRhythm Technologies, Inc.: Product Portfolio

Table 49 iRhythm Technologies, Inc.: Key Developments

Table 50 Preventice Solutions (Boston Scientific Corporation): Overview

Table 51 Preventice Solutions (Boston Scientific Corporation): Product Portfolio

Table 52 Preventice Solutions (Boston Scientific Corporation): Key Developments

Table 53 Medi-Lynx Cardiac Monitoring LLC: Overview

Table 54 Medi-Lynx Cardiac Monitoring LLC: Product Portfolio

Table 55 Medi-Lynx Cardiac Monitoring LLC: Key Developments

Table 56 ACS Diagnostics: Overview

Table 57 ACS Diagnostics: Product Portfolio

Table 58 ACS Diagnostics: Key Developments

Table 59 Abbott: Overview

Table 60 Abbott: Product Portfolio

Table 61 Abbott: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 2 Global Cardiac Arrhythmia Monitoring Devices Market Share, By Product, 2022 & 2031 (%)

Figure 3 Global Cardiac Arrhythmia Monitoring Devices Market Share, By Application, 2022 & 2031 (%)

Figure 4 Global Cardiac Arrhythmia Monitoring Devices Market Share, By End User, 2022 & 2031 (%)

Figure 5 Global Cardiac Arrhythmia Monitoring Devices Market Share, By Region, 2022 & 2031 (%)

Figure 6 Global Cardiac Arrhythmia Monitoring Devices Market Y-o-Y Growth, By Product, 2022-2031 (%)

Figure 7 Holter Monitor: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 8 ECG Devices: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 9 Mobile Cardiac Telemetry: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 10 Cardiac Event Monitors: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 11 Implantable Loop Recorders: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 12 Global Cardiac Arrhythmia Monitoring Devices Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 13 Atrial Fibrillation: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 14 Ventricular Fibrillation: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 15 Bradycardia: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 16 Global Cardiac Arrhythmia Monitoring Devices Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure 17 Hospitals: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 18 Ambulatory Surgical Centers: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 19 Diagnostic Centers: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 20 Specialty Clinics: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 21 Global Cardiac Arrhythmia Monitoring Devices Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 22 North America: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 23 Asia-Pacific: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 24 Europe: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 25 South America: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 26 Middle East and Africa: Global Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 27 North America Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 28 North America Cardiac Arrhythmia Monitoring Devices Market Share, By Product, 2022 & 2031 (%)

Figure 29 North America Cardiac Arrhythmia Monitoring Devices Market Share, By Application, 2022 & 2031 (%)

Figure 30 North America Cardiac Arrhythmia Monitoring Devices Market Share, By End User, 2022 & 2031 (%)

Figure 31 North America Cardiac Arrhythmia Monitoring Devices Market Share, By Country, 2022 & 2031 (%)

Figure 32 South America Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 33 South America Cardiac Arrhythmia Monitoring Devices Market Share, By Product, 2022 & 2031 (%)

Figure 34 South America Cardiac Arrhythmia Monitoring Devices Market Share, By Application, 2022 & 2031 (%)

Figure 35 South America Cardiac Arrhythmia Monitoring Devices Market Share, By End User, 2022 & 2031 (%)

Figure 36 South America Cardiac Arrhythmia Monitoring Devices Market Share, By Country, 2022 & 2031 (%)

Figure 37 Europe Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 38 Europe Cardiac Arrhythmia Monitoring Devices Market Share, By Product, 2022 & 2031 (%)

Figure 39 Europe Cardiac Arrhythmia Monitoring Devices Market Share, By Application, 2022 & 2031 (%)

Figure 40 Europe Cardiac Arrhythmia Monitoring Devices Market Share, By End User, 2022 & 2031 (%)

Figure 41 Europe Cardiac Arrhythmia Monitoring Devices Market Share, By Country, 2022 & 2031 (%)

Figure 42 Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 43 Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market Share, By Product, 2022 & 2031 (%)

Figure 44 Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market Share, By Application, 2022 & 2031 (%)

Figure 45 Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market Share, By End User, 2022 & 2031 (%)

Figure 46 Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market Share, By Country, 2022 & 2031 (%)

Figure 47 Middle East & Africa Cardiac Arrhythmia Monitoring Devices Market Value, 2022-2031 (US$ Million)

Figure 48 Middle East & Africa Cardiac Arrhythmia Monitoring Devices Market Share, By Product, 2022 & 2031 (%)

Figure 49 Middle East & Africa Cardiac Arrhythmia Monitoring Devices Market Share, By Application, 2022 & 2031 (%)

Figure 50 Middle East & Africa Cardiac Arrhythmia Monitoring Devices Market Share, By End User, 2022 & 2031 (%)

Figure 51 Philips Healthcare: Financials

Figure 52 GE Healthcare: Financials

Figure 53 Medtronic PLC: Financials

Figure 54 Cardiac Sense: Financials

Figure 55 BIOTRONIK: Financials

Figure 56 iRhythm Technologies, Inc.: Financials

Figure 57 Preventice Solutions (Boston Scientific Corporation): Financials

Figure 58 Medi-Lynx Cardiac Monitoring LLC: Financials

Figure 59 ACS Diagnostics: Financials

Figure 60 Abbott: Financials

글로벌 심장 부정맥 모니터링 기기 시장 – 2023-2030

Global Cardiac Arrhythmia Monitoring Devices Market - 2023-2030